0001683168-22-008722.txt : 20221230 0001683168-22-008722.hdr.sgml : 20221230 20221230170255 ACCESSION NUMBER: 0001683168-22-008722 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221229 FILED AS OF DATE: 20221230 DATE AS OF CHANGE: 20221230 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: White Chad Norman CENTRAL INDEX KEY: 0001949607 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33216 FILM NUMBER: 221502527 MAIL ADDRESS: STREET 1: 645 MOLLY LANE, SUITE 150 CITY: WOODSTOCK STATE: GA ZIP: 30189 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sonoma Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001367083 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680423298 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 5445 CONESTOGA COURT, SUITE 150 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 800-759-9305 MAIL ADDRESS: STREET 1: 5445 CONESTOGA COURT, SUITE 150 CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: Oculus Innovative Sciences, Inc. DATE OF NAME CHANGE: 20060622 4 1 ownership.xml X0306 4 2022-12-29 0 0001367083 Sonoma Pharmaceuticals, Inc. SNOA 0001949607 White Chad Norman C/O SONOMA PHARMACEUTICALS, INC. 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 0 1 0 0 Chief Financial Officer Stock option (right to buy) 1.08 2022-12-29 4 A 0 9753 A 2032-12-29 Common Stock 9753 14753 D The options vest one third each on 12/29/2023, 12/29/2024 and 12/29/2025, or upon change of control. The options were awarded and granted to Mr. White for services performed as part of the Company's annual grant of stock options. /s/ Chad N. White 2022-12-30